SGLT2 in Patients With Type 2 Diabetes Lowers Risk of Gout SGLT2 in Patients With Type 2 Diabetes Lowers Risk of Gout

A retrospective, adjusted analysis of people in China with type 2 diabetes significantly linked SGLT2 inhibitor use with a lower risk of gout compared with those receiving a DPP4 inhibitor.First Look

Source: Medscape Diabetes Headlines - February 8, 2022 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news